Masimo Co. (MASI) Director Sells $221,800.00 in Stock

Masimo Co. (NASDAQ:MASI) Director Sanford Fitch sold 2,000 shares of Masimo stock in a transaction dated Monday, December 3rd. The shares were sold at an average price of $110.90, for a total transaction of $221,800.00. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Sanford Fitch also recently made the following trade(s):

  • On Thursday, November 1st, Sanford Fitch sold 2,000 shares of Masimo stock. The shares were sold at an average price of $113.14, for a total transaction of $226,280.00.
  • On Monday, October 1st, Sanford Fitch sold 2,000 shares of Masimo stock. The shares were sold at an average price of $124.50, for a total transaction of $249,000.00.
  • On Tuesday, September 11th, Sanford Fitch sold 10,000 shares of Masimo stock. The shares were sold at an average price of $118.29, for a total transaction of $1,182,900.00.

NASDAQ:MASI opened at $108.04 on Friday. The stock has a market cap of $5.74 billion, a price-to-earnings ratio of 37.21, a PEG ratio of 2.38 and a beta of 1.07. Masimo Co. has a fifty-two week low of $80.69 and a fifty-two week high of $126.89.



Masimo (NASDAQ:MASI) last released its quarterly earnings data on Wednesday, October 31st. The medical equipment provider reported $0.71 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.02. The business had revenue of $210.58 million during the quarter, compared to analyst estimates of $207.62 million. Masimo had a net margin of 17.08% and a return on equity of 20.29%. Masimo’s revenue was up 8.9% compared to the same quarter last year. During the same period last year, the business earned $0.56 EPS. On average, equities research analysts predict that Masimo Co. will post 2.92 earnings per share for the current year.

A number of large investors have recently added to or reduced their stakes in MASI. Northwestern Mutual Wealth Management Co. bought a new stake in shares of Masimo in the second quarter worth approximately $109,000. Koshinski Asset Management Inc. bought a new stake in shares of Masimo in the third quarter worth approximately $201,000. Ibex Investors LLC bought a new stake in shares of Masimo in the third quarter worth approximately $208,000. CIBC Asset Management Inc bought a new stake in shares of Masimo in the third quarter worth approximately $227,000. Finally, Parametrica Management Ltd bought a new stake in shares of Masimo in the third quarter worth approximately $234,000. Institutional investors and hedge funds own 82.74% of the company’s stock.

A number of research firms have weighed in on MASI. Zacks Investment Research lowered shares of Masimo from a “buy” rating to a “hold” rating in a research note on Monday. UBS Group began coverage on shares of Masimo in a research note on Tuesday, November 27th. They set a “buy” rating and a $137.00 price objective for the company. BidaskClub lowered shares of Masimo from a “buy” rating to a “hold” rating in a research note on Tuesday, November 13th. Piper Jaffray Companies raised their price objective on shares of Masimo to $120.00 and gave the company a “neutral” rating in a research note on Thursday, November 1st. Finally, Stifel Nicolaus raised their price objective on shares of Masimo from $112.00 to $145.00 and gave the company a “buy” rating in a research note on Tuesday, October 2nd. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Masimo currently has an average rating of “Buy” and a consensus target price of $119.00.

TRADEMARK VIOLATION NOTICE: This piece of content was originally published by Dakota Financial News and is the property of of Dakota Financial News. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this piece of content can be accessed at https://dakotafinancialnews.com/2018/12/07/masimo-co-masi-director-sells-221800-00-in-stock.html.

About Masimo

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Featured Article: What is Depreciation?

Insider Buying and Selling by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply